{"id":"NCT01227655","sponsor":"Bial - Portela C S.A.","briefTitle":"Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.","officialTitle":"Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With \"Wearing-off\" Phenomenon Treated With Levodopa Plus a Dopa Decarboxylase Inhibitor (DDCI): a Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre Clinical Study.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03","primaryCompletion":"2012-07","completion":"2012-07","firstPosted":"2010-10-25","resultsPosted":"2015-01-13","lastUpdate":"2015-10-19"},"enrollment":427,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Parkinson's Disease"],"interventions":[{"type":"DRUG","name":"BIA 9-1067","otherNames":["Opicapone"]},{"type":"DRUG","name":"Placebo","otherNames":["placebo; PLC"]},{"type":"DRUG","name":"Levodopa","otherNames":["L-Dopa"]},{"type":"DRUG","name":"Carbidopa","otherNames":[]},{"type":"DRUG","name":"Benserazide","otherNames":[]}],"arms":[{"label":"BIA 9-1067 25 mg once daily (QD).","type":"EXPERIMENTAL"},{"label":"BIA 9-1067 50 mg once daily (QD).","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Parkinson's disease (PD) is a neurodegenerative disorder of unknown aetiology with an estimated incidence of 4.5-16/100,000 persons/year.\n\nBIA 9-1067 is currently being developed by BIAL (Portela \\& CÂª,S.A.) to be used in addition to L-DOPA (Levodopa) /carbidopa or L-DOPA (Levodopa) / preparations in PD patients. Promising results have been obtained for BIA 9-1067 in previous studies.","primaryOutcome":{"measure":"Efficacy of 2 BIA 9-1067 (25 mg, and 50 mg) Compared With Placebo, When Administered With the Existing Treatment of L-DOPA Plus a DDCI (DOPA Decarboxylase Inhibitor)","timeFrame":"14-15 weeks","effectByArm":[{"arm":"BIA 9-1067 25 mg","deltaMin":-102.8,"sd":159.42},{"arm":"BIA 9-1067 50 mg","deltaMin":-124,"sd":178.23},{"arm":"Placebo","deltaMin":-64.5,"sd":155.35}],"pValues":[]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Portugal"]},"refs":{"pmids":["28027332"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":125},"commonTop":["Dyskinesia","Constipation","Fall","Blood CPK increased","Parkinson's disease"]}}